drugset / Trial / NCT02792686
ABX464 First in Man Study
NaSingle-groupOpen-labelTreatment
Summary
This study is an open label, parallel group, single ascending dose, exploratory study performed in a single site (Centre Cap, Montpellier, France).
Timeline
- Start
- 2014-03
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obefazimod | Small molecule | 50 mg | Oral |
| Subject | Obefazimod | Small molecule | 100 mg | Oral |
| Subject | Obefazimod | Small molecule | 150 mg | Oral |
| Subject | Obefazimod | Small molecule | 200 mg | Oral |
Indications
No indication recorded.